Redeployment of Myc and E2f1-3 drives Rb-deficient cell cycles
- PMID: 26192440
- PMCID: PMC4526313
- DOI: 10.1038/ncb3210
Redeployment of Myc and E2f1-3 drives Rb-deficient cell cycles
Abstract
Robust mechanisms to control cell proliferation have evolved to maintain the integrity of organ architecture. Here, we investigated how two critical proliferative pathways, Myc and E2f, are integrated to control cell cycles in normal and Rb-deficient cells using a murine intestinal model. We show that Myc and E2f1-3 have little impact on normal G1-S transitions. Instead, they synergistically control an S-G2 transcriptional program required for normal cell divisions and maintaining crypt-villus integrity. Surprisingly, Rb deficiency results in the Myc-dependent accumulation of E2f3 protein and chromatin repositioning of both Myc and E2f3, leading to the 'super activation' of a G1-S transcriptional program, ectopic S phase entry and rampant cell proliferation. These findings reveal that Rb-deficient cells hijack and redeploy Myc and E2f3 from an S-G2 program essential for normal cell cycles to a G1-S program that re-engages ectopic cell cycles, exposing an unanticipated addiction of Rb-null cells on Myc.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
Comment in
-
RB-loss puts focus on Myc.Nat Cell Biol. 2015 Aug;17(8):968-9. doi: 10.1038/ncb3213. Nat Cell Biol. 2015. PMID: 26239529
-
Cell cycle: repurposing MYC and E2F in the absence of RB.Nat Rev Mol Cell Biol. 2015 Sep;16(9):516-7. doi: 10.1038/nrm4044. Epub 2015 Aug 12. Nat Rev Mol Cell Biol. 2015. PMID: 26265406 No abstract available.
Similar articles
-
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.Nature. 2009 Dec 17;462(7275):930-4. doi: 10.1038/nature08677. Nature. 2009. PMID: 20016602 Free PMC article.
-
Cell cycle: repurposing MYC and E2F in the absence of RB.Nat Rev Mol Cell Biol. 2015 Sep;16(9):516-7. doi: 10.1038/nrm4044. Epub 2015 Aug 12. Nat Rev Mol Cell Biol. 2015. PMID: 26265406 No abstract available.
-
RB-loss puts focus on Myc.Nat Cell Biol. 2015 Aug;17(8):968-9. doi: 10.1038/ncb3213. Nat Cell Biol. 2015. PMID: 26239529
-
Regulation of the G1/S transition phase in mesangial cells by E2F1.Kidney Int. 1999 Oct;56(4):1238-41. doi: 10.1046/j.1523-1755.1999.00705.x. Kidney Int. 1999. PMID: 10504464 Review.
-
Network calisthenics: control of E2F dynamics in cell cycle entry.Cell Cycle. 2011 Sep 15;10(18):3086-94. doi: 10.4161/cc.10.18.17350. Epub 2011 Sep 15. Cell Cycle. 2011. PMID: 21900750 Free PMC article. Review.
Cited by
-
Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family.Proc Natl Acad Sci U S A. 2017 May 9;114(19):4942-4947. doi: 10.1073/pnas.1619170114. Epub 2017 Apr 24. Proc Natl Acad Sci U S A. 2017. PMID: 28439018 Free PMC article.
-
DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways.Neoplasia. 2017 May;19(5):439-450. doi: 10.1016/j.neo.2017.03.001. Epub 2017 Apr 25. Neoplasia. 2017. PMID: 28448802 Free PMC article.
-
Establishment of Novel Prostate Cancer Risk Subtypes and A Twelve-Gene Prognostic Model.Front Mol Biosci. 2021 May 28;8:676138. doi: 10.3389/fmolb.2021.676138. eCollection 2021. Front Mol Biosci. 2021. PMID: 34124157 Free PMC article.
-
RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis.J Clin Invest. 2023 May 15;133(10):e166647. doi: 10.1172/JCI166647. J Clin Invest. 2023. PMID: 36928314 Free PMC article.
-
Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer.Signal Transduct Target Ther. 2023 Aug 16;8(1):303. doi: 10.1038/s41392-023-01516-2. Signal Transduct Target Ther. 2023. PMID: 37582751 Free PMC article.
References
-
- Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer. 2008;8:976–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
